Octapharma supports NHS in building resilient supply chain

Cohort expansion phase commences with promising results

Innovative digital transformation leads to significant improvements

Lead candidate for lung infections moves to human trials

New research highlights NHS approval gap compared to other cancers

New partnership to integrate SRD search technology

New collaboration aims to integrate AI solutions for treatment

Data presented in Los Angeles showcases therapy’s potential

Updated data from phase 2 study reveals survival benefit

Former UK PM advocates for national screening programme